Navigation Links
SurgiQuest, Inc. Secures $19 Million to Fund Commercialization and Launch the Next Generation Access Technology Cited by Surgeons as The Future of Minimally Invasive Surgery
Date:7/8/2011

ORANGE, Conn., July 8, 2011 /PRNewswire/ -- SurgiQuest, Inc. ("SurgiQuest", the "Company") today announced that the Company has closed a $19 million round of financing from both current and new investors. River Cities Capital Funds of Cincinnati, Ohio led the round followed by Fletcher Spaght Ventures of Boston, Massachusetts. Additional investments from CMEA Ventures, California Technology Ventures, LLC, Aphelion Medical Fund and other existing SurgiQuest investors completed the round. SurgiQuest will utilize the capital from the latest round to respond to increasing demand for its products and drive commercialization initiatives domestically and abroad.

SurgiQuest's patented AirSeal® Access System provides unprecedented access to the abdominal cavity during minimally invasive surgery ("MIS"). Unlike conventional insufflation and trocar systems, the Company's breakthrough integrated platform assures stable pneumoperitoneum, continuously evacuates smoke and plume when energized medical devices such as electrocautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both laparoscopic and robotic surgical procedures.

SurgiQuest's unique and unconventional product solutions enable improved MIS approaches in both laparoscopic and DaVinci® Robotic surgical procedures.

"We appreciate the faith and ongoing support that our current and new investors have shown in our technology, our people and our vision for the exciting future ahead. This funding will be used to expand growth and move us toward profitability," stated Mr. Kurt Azarbarzin, Founder and CEO of SurgiQuest. "Our organization is extremely optimistic and energized as we approach on the expansion of our breakthrough AirSeal® technology to the entire field of laparoscopic surgery."

About SurgiQuest

SurgiQuest, Inc. is a privately held venture-backed company, founded in May 2006. The Company develops, manufactures and markets innovative access technology for minimally invasive surgery.

Additional information about SurgiQuest products can be found at www.surgiquest.com.

About River Cities Capital Funds

River Cities Capital Funds is one of the most active and experienced venture funds investing in the Midwest and Southeastern United States. With $390 million under management and over 75 investments over fourteen years, River Cities has established itself as a preferred partner among the regional entrepreneurial and broader venture capital communities. For more information, visit www.rccf.com.

About Fletcher Spaght Ventures

Fletcher Spaght Ventures, L.P. is a venture capital firm investing in emerging growth healthcare and high technology companies.  Fletcher Spaght focuses on healthcare companies, including: medical devices, life science tools, biotechnology, and healthcare services; and on high technology including: information technology (IT) and IT services, Internet and e-commerce, software computer and network hardware, and communications. Additionally, Fletcher Spaght targets "convergence" opportunities that span both healthcare and IT such as MEMS in cardiac devices, software ASP in radiology and digital imaging in dentistry.  For more information, visit www.fletcherspaght.com.

CONTACT:  Gary Tegan, +1-612-889-9490


'/>"/>
SOURCE SurgiQuest, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Digital Assent Secures $7.5 Million Series B Funding
2. Precyse Secures Healthcare IT Executive Chris Powell as New President
3. Ethicon, Inc. Announces Availability of ETHICON SECURESTRAP™ 5mm Absorbable Strap Fixation Device
4. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
5. KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies
6. MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film
7. Core Essence Secures $11.5 Million Series B Financing
8. CardioFocus Secures $5M Credit Facility with Silicon Valley Bank
9. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
10. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
11. PLC Systems Secures $4 Million in Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):